HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jolanta Gozdzik Selected Research

Jolanta Gozdzik Research Topics

Disease

4Infections
10/2022 - 01/2019
4Neoplasms (Cancer)
01/2021 - 11/2012
3Hematologic Neoplasms (Hematological Malignancy)
04/2023 - 10/2020
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
10/2020 - 06/2011
2Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 10/2020
2Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
01/2022 - 09/2009
2Leukemia
10/2016 - 04/2014
1Aspergillosis
01/2024
1Communicable Diseases (Infectious Diseases)
01/2024
1Immune System Diseases (Immune Disorders)
01/2022
1Diamond-Blackfan Anemia (Anemia, Diamond Blackfan)
01/2021
1Aplastic Anemia (Anemia, Hypoplastic)
01/2021
1Nijmegen Breakage Syndrome
01/2021
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2020
1Juvenile Myelomonocytic Leukemia
10/2020
1Chronic Granulomatous Disease
01/2020
1Ocular Toxoplasmosis
11/2019
1Toxoplasmosis
11/2019
1Virus Diseases (Viral Diseases)
01/2019
1Epstein-Barr Virus Infections
01/2019
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2018
1Invasive Fungal Infections
10/2016
1Pathologic Complete Response
04/2014
1Sepsis (Septicemia)
03/2014
1Crohn Disease (Crohn's Disease)
03/2014
1Bacteremia
03/2014
1Pain (Aches)
03/2012
1Overweight
06/2011
1Alopecia (Baldness)
09/2009
1Eosinophilia
09/2009
1Exfoliative Dermatitis (Erythroderma)
09/2009
1Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive)
01/2008
1Alveolar Rhabdomyosarcoma
11/2007
1Rhabdomyosarcoma
11/2007

Drug/Important Bio-Agent (IBA)

2Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 03/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2024
1venetoclaxIBA
04/2023
1Dihydrotachysterol (AT 10)IBA
01/2021
1A-Form DNA (A-DNA)IBA
01/2021
1treosulfanIBA
10/2020
1fludarabineIBA
10/2020
1Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric
10/2020
1Immunoglobulin G (IgG)IBA
01/2019
1CD40 Ligand (CD40L)IBA
01/2019
1DNA (Deoxyribonucleic Acid)IBA
01/2019
1A-factor (Streptomyces)IBA
01/2019
1Antiviral Agents (Antivirals)IBA
01/2019
1Rituximab (Mabthera)FDA Link
01/2019
1Micafungin (FK463)FDA Link
10/2016
1Glucose (Dextrose)FDA LinkGeneric
04/2014
1Nicotinamide PhosphoribosyltransferaseIBA
04/2014
1Biomarkers (Surrogate Marker)IBA
04/2014
1Oxygen (Dioxygen)IBA
11/2012
1NitrogenIBA
11/2012
1ChemokinesIBA
11/2012
1Chemokine ReceptorsIBA
11/2012
1IronIBA
03/2012
1LeptinIBA
06/2011
1Leptin ReceptorsIBA
06/2011
1Immunoglobulin E (IgE)IBA
09/2009
1geldanamycinIBA
11/2007

Therapy/Procedure

8Hematopoietic Stem Cell Transplantation
01/2022 - 09/2009
5Stem Cell Transplantation
01/2024 - 01/2008
5Cell Transplantation
10/2022 - 01/2019
4Transplantation
01/2024 - 01/2021
4Therapeutics
10/2022 - 01/2008
3Drug Therapy (Chemotherapy)
01/2019 - 06/2011
1Haploidentical Transplantation
01/2024
1Immunotherapy
11/2012
1Central Venous Catheters
03/2012
1Length of Stay
03/2012
1Radiotherapy
06/2011